Eric Venker - Net Worth and Insider Trading
Eric Venker Net Worth
The estimated net worth of Eric Venker is at least $8 Million dollars as of 2024-11-29. Eric Venker is the President & COO of Roivant Sciences Ltd and owns about 606,525 shares of Roivant Sciences Ltd (ROIV) stock worth over $8 Million. Details can be seen in Eric Venker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Venker has not made any transactions after 2024-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Venker
Eric Venker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Venker owns 5 companies in total, including Arbutus Biopharma Corp (ABUS) , Immunovant Inc (IMVTU) , and Sio Gene Therapies Inc (SIOX) among others .
Click here to see the complete history of Eric Venker’s form 4 insider trades.
Insider Ownership Summary of Eric Venker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2020-02-18 | director |
| IMVTU | Immunovant Inc | 2020-02-18 | director |
| SIOX | Sio Gene Therapies Inc | 2020-02-17 | director |
 | | 2024-11-20 | President & COO |
| | 2020-02-18 | director |
Eric Venker Latest Holdings Summary
Eric Venker currently owns a total of 1 stock. Eric Venker owns 606,525 shares of Roivant Sciences Ltd (ROIV) as of November 20, 2024, with a value of $8 Million.
Latest Holdings of Eric Venker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd | 2024-11-20 | 606,525 | 12.69 | 7,696,802 |
Holding Weightings of Eric Venker
Eric Venker Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Venker has made a total of 30 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 30 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 100,000 shares on November 20, 2024, which brought Eric Venker around $1 Million.
Insider Trading History of Eric Venker
- 1
Eric Venker Trading Performance
Eric Venker Ownership Network
Eric Venker Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Eric Venker is the director of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Eric Venker made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 0 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Eric Venker Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Venker. You might contact Eric Venker via mailing address: C/o Roivant Sciences, Inc., 320 West 37th Street, 6th Floor, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
